Screening and evaluation of antibacterial active strains of Actinomycetes isolated from Northern Indian soil for biofilm inhibition against selected ESKAPE pathogens

Abstract

AbstractThe growing problem of antimicrobial resistance (AMR) globally has warranted the search for new and alternate anti-infective strategies. This study aimed to isolate and screen soil Actinomycetes from three different locations in Northern India for their broad-spectrum antibacterial and antibiofilm activity against certain drug-resistant bacteria from ESKAPE group. A total of 110 isolates of Actinomycetes were screened for antibacterial activity using overlay and agar-well diffusion assay against Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Ninety-five isolates showed antibacterial activity against one or more test bacteria. These isolates were tentatively identified as members of genus Streptomyces. Five isolates (IMA13, IMA25, IMA43, IMA46, and IMA47) demonstrated broad-spectrum activity against test pathogens and were subjected to production of secondary metabolites in liquid medium. Ethyl acetate fraction of culture filtrate showed MIC in the range of 64–512 µg/ml against test bacteria. The most active isolate, IMA-46, was identified by 16srRNA gene sequence analysis as Streptomyces rameus. Further, ethyl acetate fraction from S. rameus-IMA46 was used to inhibit biofilm formation at sub-MIC values. A significant level (50% to 92%) of biofilm inhibition was recorded against test pathogens. Light microscopy and SEM analysis revealed the biofilm structural changes, reduction in cell aggregation and EPS production. LC/MS analysis of the active extract of S. rameus IMA46 showed the presence of many biologically active compounds, including tetracycline and doxycycline. The present study highlights the potential of soil Actinomycetes in production of broad-spectrum anti-infective compounds in combating growing problem of AMR.